26.02.2020 • Topics

Webinar: Discover How Virtual Twin Experiences Add Value in Life Sciences Manufacturing

© poba/Getty Images
© poba/Getty Images

Life Sciences industry is undergoing a fundamental shift, driven by new technologies, e.g. personalized medicines, digital health, continuous processes, as well as the drive to lower healthcare cost and changes in re-imbursement to a value-based pricing model.

Digitalization is instrumental in facilitating a successful transformation to a flexible, agile and cost-effective pharma manufacturing. Virtual twins can significantly improve the quality and efficiency of projects in engineering and commissioning as well as help improve performance during operations and maintenance.

 

Discover How Virtual Twin Experiences Add Value in Life Sciences Manufacturing
March 26, 2020 | 10.00 a.m. (CET)

           

Join this webinar to:

  • Understand the current industry challenges and the limitations of current approaches
  • Discover how using a virtual twin approach can bring value
  • Learn from practical experiences

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read